Structure–function analysis of cytochromes P450 2B

In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure–function through determination of one ligand-free and two inhibitor-bound X-ray crystal structures of CYP2B4, which revealed many of the structural features required for binding ligands of different size and shape...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta Vol. 1770; no. 3; pp. 402 - 412
Main Authors Zhao, Yonghong, Halpert, James R.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.03.2007
Subjects
Online AccessGet full text
ISSN0304-4165
0006-3002
1872-8006
1878-2434
DOI10.1016/j.bbagen.2006.07.006

Cover

Loading…
Abstract In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure–function through determination of one ligand-free and two inhibitor-bound X-ray crystal structures of CYP2B4, which revealed many of the structural features required for binding ligands of different size and shape. Large conformational changes of several plastic regions of CYP2B4 can dramatically reshape the active site of the enzyme to fit the size and shape of the bound ligand without perturbing the overall P450 fold. Solution biophysical studies using isothermal titration calorimetry (ITC) have revealed the large difference in the thermodynamic parameters of CYP2B4 in binding inhibitors of different ring chemistry and side chains. Other studies have revealed that the effects of site-specific mutations on steady-state kinetic parameters and mechanism-based inactivation are often substrate dependent. These findings agree with the structural data that the enzymes adopt different conformations to bind various ligands. Thus, the substrate specificity of an individual enzyme is determined not only by active site residues but also non-active site residues that modulate conformational changes that are important for substrate access and rearrangement of the active site to accommodate the bound substrate.
AbstractList In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure-function through determination of one ligand-free and two inhibitor-bound X-ray crystal structures of CYP2B4, which revealed many of the structural features required for binding ligands of different size and shape. Large conformational changes of several plastic regions of CYP2B4 can dramatically reshape the active site of the enzyme to fit the size and shape of the bound ligand without perturbing the overall P450 fold. Solution biophysical studies using isothermal titration calorimetry (ITC) have revealed the large difference in the thermodynamic parameters of CYP2B4 in binding inhibitors of different ring chemistry and side chains. Other studies have revealed that the effects of site-specific mutations on steady-state kinetic parameters and mechanism-based inactivation are often substrate dependent. These findings agree with the structural data that the enzymes adopt different conformations to bind various ligands. Thus, the substrate specificity of an individual enzyme is determined not only by active site residues but also non-active site residues that modulate conformational changes that are important for substrate access and rearrangement of the active site to accommodate the bound substrate.In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure-function through determination of one ligand-free and two inhibitor-bound X-ray crystal structures of CYP2B4, which revealed many of the structural features required for binding ligands of different size and shape. Large conformational changes of several plastic regions of CYP2B4 can dramatically reshape the active site of the enzyme to fit the size and shape of the bound ligand without perturbing the overall P450 fold. Solution biophysical studies using isothermal titration calorimetry (ITC) have revealed the large difference in the thermodynamic parameters of CYP2B4 in binding inhibitors of different ring chemistry and side chains. Other studies have revealed that the effects of site-specific mutations on steady-state kinetic parameters and mechanism-based inactivation are often substrate dependent. These findings agree with the structural data that the enzymes adopt different conformations to bind various ligands. Thus, the substrate specificity of an individual enzyme is determined not only by active site residues but also non-active site residues that modulate conformational changes that are important for substrate access and rearrangement of the active site to accommodate the bound substrate.
In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure–function through determination of one ligand-free and two inhibitor-bound X-ray crystal structures of CYP2B4, which revealed many of the structural features required for binding ligands of different size and shape. Large conformational changes of several plastic regions of CYP2B4 can dramatically reshape the active site of the enzyme to fit the size and shape of the bound ligand without perturbing the overall P450 fold. Solution biophysical studies using isothermal titration calorimetry (ITC) have revealed the large difference in the thermodynamic parameters of CYP2B4 in binding inhibitors of different ring chemistry and side chains. Other studies have revealed that the effects of site-specific mutations on steady-state kinetic parameters and mechanism-based inactivation are often substrate dependent. These findings agree with the structural data that the enzymes adopt different conformations to bind various ligands. Thus, the substrate specificity of an individual enzyme is determined not only by active site residues but also non-active site residues that modulate conformational changes that are important for substrate access and rearrangement of the active site to accommodate the bound substrate.
Author Zhao, Yonghong
Halpert, James R.
Author_xml – sequence: 1
  givenname: Yonghong
  surname: Zhao
  fullname: Zhao, Yonghong
  email: yozhao@utmb.edu
– sequence: 2
  givenname: James R.
  surname: Halpert
  fullname: Halpert, James R.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16935426$$D View this record in MEDLINE/PubMed
https://www.osti.gov/biblio/910100$$D View this record in Osti.gov
BookMark eNqFkM9qFTEUh0Op2NvWNxAZN-5mmszkrwuhFrWFQgtt1yE3c8bmMjepSUa4O9_BN_RJzDgtBRd6Nr8svt8h5ztE-z54QOg1wQ3BhJ9smvXafAXftBjzBoumxB5aESnaWpb3PlrhDtOaEs4O0GFKG1yGKfYSHRCuOkZbvkL0JsfJ5inCrx8_h8nb7IKvjDfjLrlUhaGyuxzsfQxbSNU1ZbhqPx6jF4MZE7x6zCN09_nT7dl5fXn15eLs9LK2HRe5poPqBelET4wEiyUxljJCJah-YKLvJQVuZasMX_MyoATjSgyEKcsHyXB3hN4ue0PKTifrMth7G7wHm7UqFvDMvFuYhxi-TZCy3rpkYRyNhzAlzaWiUvxZ9uYRnNZb6PVDdFsTd_rJRQHoAtgYUoowPCNYz8r1Ri_K9axcY6FLlNr7v2rln2bWmKNx4__KH5YyFI3fHcT5SvAWehfnI_vg_r3gN3Q-nOM
CitedBy_id crossref_primary_10_1124_mol_107_042861
crossref_primary_10_1124_mol_107_039693
crossref_primary_10_1016_j_bpc_2016_05_007
crossref_primary_10_1021_ja403042k
crossref_primary_10_1124_mol_115_102111
crossref_primary_10_1021_bi8011803
crossref_primary_10_1021_bi800926x
crossref_primary_10_1124_dmd_116_071662
crossref_primary_10_3390_ijms23158498
crossref_primary_10_1016_j_dmpk_2018_01_001
crossref_primary_10_1021_bi800034b
crossref_primary_10_1016_j_abb_2015_08_007
crossref_primary_10_1517_17425255_4_6_733
crossref_primary_10_1124_jpet_109_164350
crossref_primary_10_1016_j_bbagen_2016_03_028
crossref_primary_10_1002_humu_22295
crossref_primary_10_1021_acs_biochem_7b00097
crossref_primary_10_1021_acs_biochem_7b01024
crossref_primary_10_1021_tx800138v
crossref_primary_10_1517_17425250903431040
crossref_primary_10_1021_acs_jcim_0c00482
crossref_primary_10_1021_bi101797v
crossref_primary_10_1016_j_bbagen_2014_12_015
crossref_primary_10_1021_acs_biochem_5b01330
crossref_primary_10_1007_s00775_008_0368_5
crossref_primary_10_1016_j_taap_2013_12_005
crossref_primary_10_1021_tx7002504
crossref_primary_10_1074_jbc_M708582200
crossref_primary_10_1124_mol_109_062570
crossref_primary_10_1016_j_pharmthera_2009_05_011
crossref_primary_10_1093_jmammal_gyy039
crossref_primary_10_1074_jbc_M110_180646
crossref_primary_10_1007_s00775_009_0580_y
crossref_primary_10_1074_jbc_M707470200
crossref_primary_10_1016_j_tplants_2014_11_002
crossref_primary_10_1124_jpet_109_158782
crossref_primary_10_1002_jmr_909
crossref_primary_10_1111_j_1742_4658_2011_08411_x
crossref_primary_10_1016_j_abb_2009_11_026
crossref_primary_10_1021_bi300894z
crossref_primary_10_1007_s10886_013_0335_7
crossref_primary_10_1124_dmd_122_000853
crossref_primary_10_1517_17425250802500028
crossref_primary_10_1128_mBio_00307_10
crossref_primary_10_1007_s00894_008_0294_z
crossref_primary_10_1021_bi9003765
crossref_primary_10_1016_j_abb_2012_12_016
crossref_primary_10_1021_bi100914z
crossref_primary_10_1124_dmd_111_042176
Cites_doi 10.1016/j.abb.2004.03.014
10.1016/S1097-2765(00)80408-6
10.1016/j.abb.2003.12.035
10.1016/j.bbrc.2005.08.080
10.2174/1389200013338478
10.1021/tx020040b
10.1074/jbc.M212515200
10.1097/00008571-200310000-00005
10.1021/bi00180a040
10.1124/jpet.104.069757
10.1124/dmd.31.4.398
10.1016/S0959-440X(03)00003-4
10.1021/tx050100o
10.1124/jpet.301.1.160
10.2174/1389200013338612
10.1097/01213011-200512000-00004
10.1016/0167-4838(93)90238-M
10.1073/pnas.80.13.3958
10.1021/tx050256o
10.1006/abbi.2001.2574
10.1038/sj.tpj.6500157
10.1097/01.fpc.0000189797.03845.90
10.1021/bi034556l
10.1126/science.1079237
10.1074/jbc.M511464200
10.1124/jpet.103.050260
10.1124/dmd.105.003749
10.1074/jbc.M500158200
10.1016/j.bbrc.2005.08.192
10.1016/j.abb.2004.12.014
10.1074/jbc.M509696200
10.1074/jbc.M403349200
10.1124/dmd.105.004200
10.1021/bi0273922
10.1016/S0167-4838(00)00268-5
10.1086/499364
10.1124/jpet.300.2.549
10.1042/0264-6021:3390371
10.1073/pnas.2133986100
10.1124/jpet.104.071670
10.2133/dmpk.19.444
10.1124/dmd.30.1.86
10.1016/0003-9861(91)90121-X
10.1006/abbi.2001.2504
10.1074/jbc.M405427200
10.1086/499369
10.1021/tx020057u
10.1016/S0021-9258(18)54602-0
10.1016/S0021-9258(17)36209-9
10.1124/mol.59.3.475
10.1016/j.tibtech.2003.09.001
10.2174/1389200033489262
10.1080/10629360412331319835
ContentType Journal Article
Copyright 2006 Elsevier B.V.
Copyright_xml – notice: 2006 Elsevier B.V.
CorporateAuthor Stanford Linear Accelerator Center (SLAC)
CorporateAuthor_xml – name: Stanford Linear Accelerator Center (SLAC)
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
OTOTI
DOI 10.1016/j.bbagen.2006.07.006
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
OSTI.GOV
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1872-8006
1878-2434
EndPage 412
ExternalDocumentID 910100
16935426
10_1016_j_bbagen_2006_07_006
S0304416506002030
Genre Journal Article
Review
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIEHS NIH HHS
  grantid: ES06676
– fundername: NIEHS NIH HHS
  grantid: ES03619
– fundername: NIEHS NIH HHS
  grantid: T32-ES07254
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABEFU
ABFNM
ABGSF
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UQL
WH7
WUQ
XJT
XPP
~G-
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
-~X
.55
.GJ
AAYJJ
ABJNI
AFFNX
AI.
CGR
CUY
CVF
ECM
EIF
F5P
H~9
K-O
MVM
NPM
PKN
RIG
TWZ
UHS
VH1
X7M
Y6R
YYP
ZE2
ZGI
~KM
7X8
OTOTI
ID FETCH-LOGICAL-c367t-4f9d7137d1a8ec081ac45148e9df57dd84e6c829a6b6666e975697f159c6f8503
IEDL.DBID AIKHN
ISSN 0304-4165
0006-3002
IngestDate Fri May 19 01:41:38 EDT 2023
Thu Jul 10 22:54:24 EDT 2025
Wed Feb 19 01:49:15 EST 2025
Thu Apr 24 23:07:35 EDT 2025
Tue Jul 01 00:21:52 EDT 2025
Fri Feb 23 02:32:39 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords PR
Cymal-5
DTT
Δ S
4CPI
17EE
Function
P450 or CYP
Substrate specificity
QM
Structure
tTEPA
Cytochrome P450
BEI
S.D
1PI
EDTA
CYP2B1dH (CYP2B4dH, CYP2B6dH, and CYP2B11dH)
4PI
7-EFC
DMZ
Δ H
CYP2B
CPA
QSAR
1BI
ITC
MES
1CPI
7-BR
Conformation
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c367t-4f9d7137d1a8ec081ac45148e9df57dd84e6c829a6b6666e975697f159c6f8503
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
USDOE
SLAC-REPRINT-2007-170
AC02-76SF00515
PMID 16935426
PQID 68948750
PQPubID 23479
PageCount 11
ParticipantIDs osti_scitechconnect_910100
proquest_miscellaneous_68948750
pubmed_primary_16935426
crossref_primary_10_1016_j_bbagen_2006_07_006
crossref_citationtrail_10_1016_j_bbagen_2006_07_006
elsevier_sciencedirect_doi_10_1016_j_bbagen_2006_07_006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2007-03-00
PublicationDateYYYYMMDD 2007-03-01
PublicationDate_xml – month: 03
  year: 2007
  text: 2007-03-00
PublicationDecade 2000
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
– name: United States
PublicationTitle Biochimica et biophysica acta
PublicationTitleAlternate Biochim Biophys Acta
PublicationYear 2007
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Kumar, Scott, Liu, Halpert (bib15) 2003; 278
Wester, Yano, Schoch, Yang, Griffin, Stout, Johnson (bib35) 2004; 279
Ribaudo, Haas, Tierney, Kim, Wilkinson, Gulick, Clifford, Marzolini, Fletcher, Tashima, Kuritzkes, Acosta (bib26) 2006; 42
Wang, Sonnerborg, Rane, Josephson, Lundgren, Stahle, Ingelman-Sundberg (bib27) 2006; 16
Gasser, Negishi, Philpot (bib6) 1988; 33
Lin, Kent, Hollenberg (bib46) 2002; 301
Jinno, Tanaka-Kagawa, Ohno, Makino, Matsushima, Hanioka, Ando (bib56) 2003; 31
Sridar, Harleton, Hollenberg (bib20) 2005; 338
Kedzie, Grimm, Chen, Halpert (bib3) 1993; 1164
Wang, Negishi (bib1) 2003; 4
Kedzie, Balfour, Escobar, Grimm, He, Pepperl, Regan, Stevens, Halpert (bib4) 1991; 266
Scott, He, Halpert (bib17) 2002; 15
Kent, Lin, Mills, Regal, Hollenberg (bib19) 2006; 19
Norinder (bib36) 2005; 16
Nolan, Phillips, Mallal (bib55) 2006; 42
Mizukami, Sobawa, Suwa, Muramatsu, Fujii-Kuriyama (bib5) 1983; 80
Scott, White, He, Johnson, Stout, Halpert (bib12) 2004; 279
Li, Liu, Scott, Grater, Halpert, Luo, Shen, Jiang (bib40) 2005; 33
He, Luo, Klekotka, Burnett, Halpert (bib48) 1994; 33
Kumar, Chen, Waxman, Halpert (bib41) 2005; 280
Spatzenegger, Wang, He, Wester, Johnson, Halpert (bib38) 2001; 59
Lin, Zhang, Waskell, Hollenberg (bib47) 2003; 306
Kumar, Halpert (bib23) 2005; 338
Wester, Johnson, Marques-Soares, Dijols, Dansette, Mansuy, Stout (bib32) 2003; 42
Turner (bib54) 2003; 21
Bumpus, Sridar, Kent, Hollenberg (bib29) 2005; 33
Kent, Mills, Rajnarayanan, Alworth, Hollenberg (bib45) 2002; 300
Kent, Juschyshyn, Hollenberg (bib43) 2001; 2
Zhao, White, Muralidhara, Sun, Halpert, Stout (bib13) 2006; 281
Lin, Kent, Zhang, Waskell, Hollenberg (bib22) 2004; 311
Domanski, Halpert (bib7) 2001; 2
Scott, Spatzenegger, Halpert (bib10) 2001; 395
Szklarz, Halpert (bib44) 1998; 26
Domanski, He, Scott, Wang, Halpert (bib33) 2001; 394
Iwasaki, Yoshimura, Asahi, Saito, Sakai, Morita, Takenaka, Inoda, Kashiyama, Aoyama, Nakabayashi, Omori, Kuwabara, Izumi, Nakamura, Takanaka, Nakayama, Takeuchi, Nakamura, Kametani, Terauchi, Hashizume, Nagayama, Kume, Achira, Kawai, Kawashiro, Nakamura, Nakai, Kagayama, Shiraga, Niwa, Yoshimura, Morita, Ohsawa, Tani, Osawa, Ida, Noguchi (bib30) 2004; 19
Kedzie, Philpot, Halpert (bib2) 1991; 291
Muralidhara, Negi, Chin, Braun, Halpert (bib14) 2006; 281
Xie, Yasar, Lundgren, Griskevicius, Terelius, Hassan, Rane (bib25) 2003; 3
von Weymarn, Blobaum, Hollenberg (bib49) 2004; 425
Weber, Salemme (bib37) 2003; 13
Wang, Halpert (bib39) 2002; 30
Kirchheiner, Klein, Meineke, Sasse, Zanger, Murdter, Roots, Brockmoller (bib24) 2003; 13
Lin, Zhang, Waskell, Hollenberg (bib51) 2005; 18
Scott, He, Wester, White, Chin, Halpert, Johnson, Stout (bib11) 2003; 100
Noble, Miles, Chapman, Lysek, MacKay, Reid, Hanzlik, Munro (bib42) 1999; 339
Von Weymarn, Sridar, Hollenberg (bib21) 2004; 311
Schoemaker, Mink, Wubbolts (bib52) 2003; 299
Williams, Cosme, Sridhar, Johnson, McRee (bib9) 2000; 5
Li, Schwaneberg, Fischer, Schmitt, Pleiss, Lutz-Wahl, Schmid (bib53) 2001; 1545
Lin, Kent, Zhang, Waskell, Hollenberg (bib50) 2003; 16
Honma, Li, Liu, Scott, Halpert (bib16) 2005; 435
Wester, Johnson, Marques-Soares, Dansette, Mansuy, Stout (bib31) 2003; 42
Klein, Lang, Saussele, Barbosa-Sicard, Schunck, Eichelbaum, Schwab, Zanger (bib28) 2005; 15
Poulos, Finzel, Gunsalus, Wagner, Kraut (bib8) 1985; 260
Scott, Liu, Qun He, Li, Halpert (bib18) 2004; 423
Spatzenegger (10.1016/j.bbagen.2006.07.006_bib38) 2001; 59
Scott (10.1016/j.bbagen.2006.07.006_bib18) 2004; 423
Scott (10.1016/j.bbagen.2006.07.006_bib12) 2004; 279
Norinder (10.1016/j.bbagen.2006.07.006_bib36) 2005; 16
Kedzie (10.1016/j.bbagen.2006.07.006_bib4) 1991; 266
Bumpus (10.1016/j.bbagen.2006.07.006_bib29) 2005; 33
Lin (10.1016/j.bbagen.2006.07.006_bib22) 2004; 311
Klein (10.1016/j.bbagen.2006.07.006_bib28) 2005; 15
Jinno (10.1016/j.bbagen.2006.07.006_bib56) 2003; 31
Wang (10.1016/j.bbagen.2006.07.006_bib1) 2003; 4
Scott (10.1016/j.bbagen.2006.07.006_bib17) 2002; 15
He (10.1016/j.bbagen.2006.07.006_bib48) 1994; 33
Kedzie (10.1016/j.bbagen.2006.07.006_bib2) 1991; 291
Kent (10.1016/j.bbagen.2006.07.006_bib45) 2002; 300
Sridar (10.1016/j.bbagen.2006.07.006_bib20) 2005; 338
Ribaudo (10.1016/j.bbagen.2006.07.006_bib26) 2006; 42
von Weymarn (10.1016/j.bbagen.2006.07.006_bib49) 2004; 425
Wester (10.1016/j.bbagen.2006.07.006_bib35) 2004; 279
Szklarz (10.1016/j.bbagen.2006.07.006_bib44) 1998; 26
Nolan (10.1016/j.bbagen.2006.07.006_bib55) 2006; 42
Honma (10.1016/j.bbagen.2006.07.006_bib16) 2005; 435
Lin (10.1016/j.bbagen.2006.07.006_bib47) 2003; 306
Lin (10.1016/j.bbagen.2006.07.006_bib50) 2003; 16
Kumar (10.1016/j.bbagen.2006.07.006_bib23) 2005; 338
Wester (10.1016/j.bbagen.2006.07.006_bib32) 2003; 42
Schoemaker (10.1016/j.bbagen.2006.07.006_bib52) 2003; 299
Von Weymarn (10.1016/j.bbagen.2006.07.006_bib21) 2004; 311
Poulos (10.1016/j.bbagen.2006.07.006_bib8) 1985; 260
Zhao (10.1016/j.bbagen.2006.07.006_bib13) 2006; 281
Lin (10.1016/j.bbagen.2006.07.006_bib46) 2002; 301
Iwasaki (10.1016/j.bbagen.2006.07.006_bib30) 2004; 19
Mizukami (10.1016/j.bbagen.2006.07.006_bib5) 1983; 80
Wester (10.1016/j.bbagen.2006.07.006_bib31) 2003; 42
Kent (10.1016/j.bbagen.2006.07.006_bib43) 2001; 2
Weber (10.1016/j.bbagen.2006.07.006_bib37) 2003; 13
Wang (10.1016/j.bbagen.2006.07.006_bib39) 2002; 30
Scott (10.1016/j.bbagen.2006.07.006_bib11) 2003; 100
Gasser (10.1016/j.bbagen.2006.07.006_bib6) 1988; 33
Kedzie (10.1016/j.bbagen.2006.07.006_bib3) 1993; 1164
Lin (10.1016/j.bbagen.2006.07.006_bib51) 2005; 18
Li (10.1016/j.bbagen.2006.07.006_bib53) 2001; 1545
Xie (10.1016/j.bbagen.2006.07.006_bib25) 2003; 3
Muralidhara (10.1016/j.bbagen.2006.07.006_bib14) 2006; 281
Wang (10.1016/j.bbagen.2006.07.006_bib27) 2006; 16
Williams (10.1016/j.bbagen.2006.07.006_bib9) 2000; 5
Kumar (10.1016/j.bbagen.2006.07.006_bib15) 2003; 278
Domanski (10.1016/j.bbagen.2006.07.006_bib7) 2001; 2
Kent (10.1016/j.bbagen.2006.07.006_bib19) 2006; 19
Scott (10.1016/j.bbagen.2006.07.006_bib10) 2001; 395
Li (10.1016/j.bbagen.2006.07.006_bib40) 2005; 33
Kirchheiner (10.1016/j.bbagen.2006.07.006_bib24) 2003; 13
Domanski (10.1016/j.bbagen.2006.07.006_bib33) 2001; 394
Turner (10.1016/j.bbagen.2006.07.006_bib54) 2003; 21
Kumar (10.1016/j.bbagen.2006.07.006_bib41) 2005; 280
Noble (10.1016/j.bbagen.2006.07.006_bib42) 1999; 339
References_xml – volume: 435
  start-page: 157
  year: 2005
  end-page: 165
  ident: bib16
  article-title: Functional role of residues in the helix B′ region of cytochrome P450 2B1
  publication-title: Arch. Biochem. Biophys.
– volume: 299
  start-page: 1694
  year: 2003
  end-page: 1697
  ident: bib52
  article-title: Dispelling the myths—Biocatalysis in industrial synthesis
  publication-title: Science
– volume: 31
  start-page: 398
  year: 2003
  end-page: 403
  ident: bib56
  article-title: Functional characterization of cytochrome P450 2B6 allelic variants
  publication-title: Drug Metab. Dispos.
– volume: 300
  start-page: 549
  year: 2002
  end-page: 558
  ident: bib45
  article-title: Effect of 17-alpha-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 338
  start-page: 456
  year: 2005
  end-page: 464
  ident: bib23
  article-title: Use of directed evolution of mammalian cytochromes P450 for investigating the molecular basis of enzyme function and generating novel biocatalysts
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 339
  start-page: 371
  year: 1999
  end-page: 379
  ident: bib42
  article-title: Roles of key active-site residues in flavocytochrome P450 BM3
  publication-title: Biochem. J.
– volume: 266
  start-page: 22515
  year: 1991
  end-page: 22521
  ident: bib4
  article-title: Molecular basis for a functionally unique cytochrome P450IIB1 variant
  publication-title: J. Biol. Chem.
– volume: 26
  start-page: 1179
  year: 1998
  end-page: 1184
  ident: bib44
  article-title: Molecular basis of P450 inhibition and activation: implications for drug development and drug therapy
  publication-title: Drug Metab. Dispos.
– volume: 33
  start-page: 4419
  year: 1994
  end-page: 4424
  ident: bib48
  article-title: Structural determinants of cytochrome P450 2B1 specificity: evidence for five substrate recognition sites
  publication-title: Biochemistry
– volume: 1164
  start-page: 124
  year: 1993
  end-page: 132
  ident: bib3
  article-title: Hybrid enzymes for structure–function analysis of cytochrome P-450 2B11
  publication-title: Biochim. Biophys. Acta
– volume: 100
  start-page: 13196
  year: 2003
  end-page: 13201
  ident: bib11
  article-title: An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 279
  start-page: 27294
  year: 2004
  end-page: 27301
  ident: bib12
  article-title: Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl)imidazole at 1.9-A resolution: insight into the range of P450 conformations and the coordination of redox partner binding
  publication-title: J. Biol. Chem.
– volume: 311
  start-page: 855
  year: 2004
  end-page: 863
  ident: bib22
  article-title: The functional role of threonine-205 in the mechanism-based inactivation of P450 2B1 by two ethynyl substrates: the importance of the F helix in catalysis
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 5
  start-page: 121
  year: 2000
  end-page: 131
  ident: bib9
  article-title: Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity
  publication-title: Mol. Cell
– volume: 278
  start-page: 17178
  year: 2003
  end-page: 17184
  ident: bib15
  article-title: A rational approach to re-engineer cytochrome P450 2B1 regioselectivity based on the crystal structure of cytochrome P450 2C5
  publication-title: J. Biol. Chem.
– volume: 16
  start-page: 191
  year: 2006
  end-page: 198
  ident: bib27
  article-title: Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz
  publication-title: Pharmacogenet. Genomics
– volume: 338
  start-page: 386
  year: 2005
  end-page: 393
  ident: bib20
  article-title: Roles of the threonine 407, aspartic acid 417, and threonine 419 residues in P450 2B1 in metabolism
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 4
  start-page: 515
  year: 2003
  end-page: 525
  ident: bib1
  article-title: Transcriptional regulation of cytochrome P4502B genes by nuclear receptors
  publication-title: Curr. Drug Metab.
– volume: 42
  start-page: 6370
  year: 2003
  end-page: 6379
  ident: bib31
  article-title: Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes
  publication-title: Biochemistry
– volume: 16
  start-page: 129
  year: 2003
  end-page: 136
  ident: bib50
  article-title: Mutation of tyrosine 190 to alanine eliminates the inactivation of cytochrome P450 2B1 by peroxynitrite
  publication-title: Chem. Res. Toxicol.
– volume: 1545
  start-page: 114
  year: 2001
  end-page: 121
  ident: bib53
  article-title: Rational evolution of a medium chain-specific cytochrome P-450 BM-3 variant
  publication-title: Biochim. Biophys. Acta
– volume: 33
  start-page: 795
  year: 2005
  end-page: 802
  ident: bib29
  article-title: The naturally occurring cytochrome P450 (P450) 2B6 K262R mutant of P450 2B6 exhibits alterations in substrate metabolism and inactivation
  publication-title: Drug Metab. Dispos.
– volume: 15
  start-page: 1407
  year: 2002
  end-page: 1413
  ident: bib17
  article-title: Substrate routes to the buried active site may vary among cytochromes P450: mutagenesis of the F–G region in P450 2B1
  publication-title: Chem. Res. Toxicol.
– volume: 42
  start-page: 9335
  year: 2003
  end-page: 9345
  ident: bib32
  article-title: Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1 A resolution: evidence for an induced fit model of substrate binding
  publication-title: Biochemistry
– volume: 394
  start-page: 21
  year: 2001
  end-page: 28
  ident: bib33
  article-title: The role of cytochrome B1 substrate recognition site residues 115, 294, 297, 298, and 362 in the oxidation of steroids and 7-alkoxycoumarins
  publication-title: Arch. Biochem. Biophys.
– volume: 21
  start-page: 474
  year: 2003
  end-page: 478
  ident: bib54
  article-title: Directed evolution of enzymes for applied biocatalysis
  publication-title: Trends Biotechnol.
– volume: 30
  start-page: 86
  year: 2002
  end-page: 95
  ident: bib39
  article-title: Combined three-dimensional quantitative structure–activity relationship analysis of cytochrome P450 2B6 substrates and protein homology modeling
  publication-title: Drug Metab. Dispos.
– volume: 19
  start-page: 279
  year: 2006
  end-page: 287
  ident: bib19
  article-title: Identification of 17-alpha-ethynylestradiol-modified active site, peptides and glutathione conjugates formed during metabolism, and inactivation of P450s 2B1 and 2B6
  publication-title: Chem. Res. Toxicol.
– volume: 13
  start-page: 619
  year: 2003
  end-page: 626
  ident: bib24
  article-title: Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6
  publication-title: Pharmacogenetics
– volume: 260
  start-page: 16122
  year: 1985
  end-page: 16130
  ident: bib8
  article-title: The 2.6-A crystal structure of
  publication-title: J. Biol. Chem.
– volume: 281
  start-page: 8051
  year: 2006
  end-page: 8061
  ident: bib14
  article-title: Conformational flexibility of mammalian cytochrome P4502B4 in binding imidazole inhibitors with different ring chemistry and side chains—Solution thermodynamics and molecular modeling
  publication-title: J. Biol. Chem.
– volume: 42
  start-page: 408
  year: 2006
  end-page: 410
  ident: bib55
  article-title: Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance
  publication-title: Clin. Infect. Dis.
– volume: 281
  start-page: 5973
  year: 2006
  end-page: 5981
  ident: bib13
  article-title: Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction
  publication-title: J. Biol. Chem.
– volume: 18
  start-page: 1203
  year: 2005
  end-page: 1210
  ident: bib51
  article-title: The highly conserved Glu149 and Tyr190 residues contribute to peroxynitrite-mediated nitrotyrosine formation and the catalytic activity of cytochrome P450 2B1
  publication-title: Chem. Res. Toxicol.
– volume: 59
  start-page: 475
  year: 2001
  end-page: 484
  ident: bib38
  article-title: Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles
  publication-title: Mol. Pharmacol.
– volume: 306
  start-page: 744
  year: 2003
  end-page: 751
  ident: bib47
  article-title: Threonine-205 in the F helix of p450 2B1 contributes to androgen 16 beta-hydroxylation activity and mechanism-based inactivation
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 2
  start-page: 215
  year: 2001
  end-page: 243
  ident: bib43
  article-title: Mechanism-based inactivators as probes of cytochrome P450 structure and function
  publication-title: Curr. Drug Metab.
– volume: 15
  start-page: 861
  year: 2005
  end-page: 873
  ident: bib28
  article-title: Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz
  publication-title: Pharmacogenet. Genomics
– volume: 301
  start-page: 160
  year: 2002
  end-page: 167
  ident: bib46
  article-title: Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 80
  start-page: 3958
  year: 1983
  end-page: 3962
  ident: bib5
  article-title: Gene structure of a phenobarbital-inducible cytochrome P-450 in rat liver
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 2
  start-page: 117
  year: 2001
  end-page: 137
  ident: bib7
  article-title: Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis
  publication-title: Curr. Drug Metab.
– volume: 33
  start-page: 910
  year: 2005
  end-page: 919
  ident: bib40
  article-title: Possible pathway(s) of testosterone egress from the active site of cytochrome P450 2B1: a steered molecular dynamics simulation
  publication-title: Drug Metab. Dispos.
– volume: 395
  start-page: 57
  year: 2001
  end-page: 68
  ident: bib10
  article-title: A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function
  publication-title: Arch. Biochem. Biophys.
– volume: 291
  start-page: 176
  year: 1991
  end-page: 186
  ident: bib2
  article-title: Functional expression of mammalian cytochromes P450IIB in the yeast
  publication-title: Arch. Biochem. Biophys.
– volume: 42
  start-page: 401
  year: 2006
  end-page: 407
  ident: bib26
  article-title: Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an adult AIDS clinical trials group study
  publication-title: Clin. Infect. Dis.
– volume: 33
  start-page: 22
  year: 1988
  end-page: 30
  ident: bib6
  article-title: Primary structures of multiple forms of cytochrome P450 isozyme 2 derived from rabbit pulmonary and hepatic cDNAs
  publication-title: Mol. Pharmacol.
– volume: 279
  start-page: 35630
  year: 2004
  end-page: 35637
  ident: bib35
  article-title: The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution
  publication-title: J. Biol. Chem.
– volume: 280
  start-page: 19569
  year: 2005
  end-page: 19575
  ident: bib41
  article-title: Directed evolution of mammalian cytochrome P450 2B1: mutations outside of the active site enhance the metabolism of several substrates, including the anticancer prodrugs cyclophosphamide and ifosfamide
  publication-title: J. Biol. Chem.
– volume: 16
  start-page: 1
  year: 2005
  end-page: 11
  ident: bib36
  article-title: In silico modelling of ADMET—a minireview of work from 2000 to 2004
  publication-title: SAR QSAR Environ. Res.
– volume: 423
  start-page: 266
  year: 2004
  end-page: 276
  ident: bib18
  article-title: Mutagenesis and molecular dynamics suggest structural and functional roles for residues in the N-terminal portion of the cytochrome P450 2B1 I helix
  publication-title: Arch. Biochem. Biophys.
– volume: 3
  start-page: 53
  year: 2003
  end-page: 61
  ident: bib25
  article-title: Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation
  publication-title: Pharmacogenomics J.
– volume: 425
  start-page: 95
  year: 2004
  end-page: 105
  ident: bib49
  article-title: The mechanism-based inactivation of P450 2B4 by tert-butyl 1-methyl-2-propynyl ether: structural determination of the adducts to the p450 heme
  publication-title: Arch. Biochem. Biophys.
– volume: 311
  start-page: 71
  year: 2004
  end-page: 79
  ident: bib21
  article-title: Identification of amino acid residues involved in the inactivation of cytochrome P450 2B1 by two acetylenic compounds: the role of three residues in nonsubstrate recognition sites
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 19
  start-page: 444
  year: 2004
  end-page: 4452
  ident: bib30
  article-title: Functional characterization of single nucleotide polymorphisms with amino acid substitution in CYP1A2, CYP2A6, and CYP2B6 found in the Japanese population
  publication-title: Drug Metab. Pharmacokinet.
– volume: 13
  start-page: 115
  year: 2003
  end-page: 121
  ident: bib37
  article-title: Applications of calorimetric methods to drug discovery and the study of protein interactions
  publication-title: Curr. Opin. Struct. Biol.
– volume: 425
  start-page: 95
  year: 2004
  ident: 10.1016/j.bbagen.2006.07.006_bib49
  article-title: The mechanism-based inactivation of P450 2B4 by tert-butyl 1-methyl-2-propynyl ether: structural determination of the adducts to the p450 heme
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1016/j.abb.2004.03.014
– volume: 5
  start-page: 121
  year: 2000
  ident: 10.1016/j.bbagen.2006.07.006_bib9
  article-title: Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity
  publication-title: Mol. Cell
  doi: 10.1016/S1097-2765(00)80408-6
– volume: 423
  start-page: 266
  year: 2004
  ident: 10.1016/j.bbagen.2006.07.006_bib18
  article-title: Mutagenesis and molecular dynamics suggest structural and functional roles for residues in the N-terminal portion of the cytochrome P450 2B1 I helix
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1016/j.abb.2003.12.035
– volume: 33
  start-page: 22
  year: 1988
  ident: 10.1016/j.bbagen.2006.07.006_bib6
  article-title: Primary structures of multiple forms of cytochrome P450 isozyme 2 derived from rabbit pulmonary and hepatic cDNAs
  publication-title: Mol. Pharmacol.
– volume: 338
  start-page: 456
  year: 2005
  ident: 10.1016/j.bbagen.2006.07.006_bib23
  article-title: Use of directed evolution of mammalian cytochromes P450 for investigating the molecular basis of enzyme function and generating novel biocatalysts
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2005.08.080
– volume: 2
  start-page: 215
  year: 2001
  ident: 10.1016/j.bbagen.2006.07.006_bib43
  article-title: Mechanism-based inactivators as probes of cytochrome P450 structure and function
  publication-title: Curr. Drug Metab.
  doi: 10.2174/1389200013338478
– volume: 16
  start-page: 129
  year: 2003
  ident: 10.1016/j.bbagen.2006.07.006_bib50
  article-title: Mutation of tyrosine 190 to alanine eliminates the inactivation of cytochrome P450 2B1 by peroxynitrite
  publication-title: Chem. Res. Toxicol.
  doi: 10.1021/tx020040b
– volume: 278
  start-page: 17178
  year: 2003
  ident: 10.1016/j.bbagen.2006.07.006_bib15
  article-title: A rational approach to re-engineer cytochrome P450 2B1 regioselectivity based on the crystal structure of cytochrome P450 2C5
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M212515200
– volume: 13
  start-page: 619
  year: 2003
  ident: 10.1016/j.bbagen.2006.07.006_bib24
  article-title: Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6
  publication-title: Pharmacogenetics
  doi: 10.1097/00008571-200310000-00005
– volume: 33
  start-page: 4419
  year: 1994
  ident: 10.1016/j.bbagen.2006.07.006_bib48
  article-title: Structural determinants of cytochrome P450 2B1 specificity: evidence for five substrate recognition sites
  publication-title: Biochemistry
  doi: 10.1021/bi00180a040
– volume: 311
  start-page: 71
  year: 2004
  ident: 10.1016/j.bbagen.2006.07.006_bib21
  article-title: Identification of amino acid residues involved in the inactivation of cytochrome P450 2B1 by two acetylenic compounds: the role of three residues in nonsubstrate recognition sites
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.104.069757
– volume: 31
  start-page: 398
  year: 2003
  ident: 10.1016/j.bbagen.2006.07.006_bib56
  article-title: Functional characterization of cytochrome P450 2B6 allelic variants
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.31.4.398
– volume: 13
  start-page: 115
  year: 2003
  ident: 10.1016/j.bbagen.2006.07.006_bib37
  article-title: Applications of calorimetric methods to drug discovery and the study of protein interactions
  publication-title: Curr. Opin. Struct. Biol.
  doi: 10.1016/S0959-440X(03)00003-4
– volume: 18
  start-page: 1203
  year: 2005
  ident: 10.1016/j.bbagen.2006.07.006_bib51
  article-title: The highly conserved Glu149 and Tyr190 residues contribute to peroxynitrite-mediated nitrotyrosine formation and the catalytic activity of cytochrome P450 2B1
  publication-title: Chem. Res. Toxicol.
  doi: 10.1021/tx050100o
– volume: 301
  start-page: 160
  year: 2002
  ident: 10.1016/j.bbagen.2006.07.006_bib46
  article-title: Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.301.1.160
– volume: 2
  start-page: 117
  year: 2001
  ident: 10.1016/j.bbagen.2006.07.006_bib7
  article-title: Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis
  publication-title: Curr. Drug Metab.
  doi: 10.2174/1389200013338612
– volume: 15
  start-page: 861
  year: 2005
  ident: 10.1016/j.bbagen.2006.07.006_bib28
  article-title: Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz
  publication-title: Pharmacogenet. Genomics
  doi: 10.1097/01213011-200512000-00004
– volume: 1164
  start-page: 124
  year: 1993
  ident: 10.1016/j.bbagen.2006.07.006_bib3
  article-title: Hybrid enzymes for structure–function analysis of cytochrome P-450 2B11
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/0167-4838(93)90238-M
– volume: 80
  start-page: 3958
  year: 1983
  ident: 10.1016/j.bbagen.2006.07.006_bib5
  article-title: Gene structure of a phenobarbital-inducible cytochrome P-450 in rat liver
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.80.13.3958
– volume: 19
  start-page: 279
  year: 2006
  ident: 10.1016/j.bbagen.2006.07.006_bib19
  article-title: Identification of 17-alpha-ethynylestradiol-modified active site, peptides and glutathione conjugates formed during metabolism, and inactivation of P450s 2B1 and 2B6
  publication-title: Chem. Res. Toxicol.
  doi: 10.1021/tx050256o
– volume: 395
  start-page: 57
  year: 2001
  ident: 10.1016/j.bbagen.2006.07.006_bib10
  article-title: A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1006/abbi.2001.2574
– volume: 3
  start-page: 53
  year: 2003
  ident: 10.1016/j.bbagen.2006.07.006_bib25
  article-title: Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation
  publication-title: Pharmacogenomics J.
  doi: 10.1038/sj.tpj.6500157
– volume: 16
  start-page: 191
  year: 2006
  ident: 10.1016/j.bbagen.2006.07.006_bib27
  article-title: Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz
  publication-title: Pharmacogenet. Genomics
  doi: 10.1097/01.fpc.0000189797.03845.90
– volume: 42
  start-page: 9335
  year: 2003
  ident: 10.1016/j.bbagen.2006.07.006_bib32
  article-title: Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1 A resolution: evidence for an induced fit model of substrate binding
  publication-title: Biochemistry
  doi: 10.1021/bi034556l
– volume: 299
  start-page: 1694
  year: 2003
  ident: 10.1016/j.bbagen.2006.07.006_bib52
  article-title: Dispelling the myths—Biocatalysis in industrial synthesis
  publication-title: Science
  doi: 10.1126/science.1079237
– volume: 281
  start-page: 5973
  year: 2006
  ident: 10.1016/j.bbagen.2006.07.006_bib13
  article-title: Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M511464200
– volume: 306
  start-page: 744
  year: 2003
  ident: 10.1016/j.bbagen.2006.07.006_bib47
  article-title: Threonine-205 in the F helix of p450 2B1 contributes to androgen 16 beta-hydroxylation activity and mechanism-based inactivation
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.103.050260
– volume: 33
  start-page: 795
  year: 2005
  ident: 10.1016/j.bbagen.2006.07.006_bib29
  article-title: The naturally occurring cytochrome P450 (P450) 2B6 K262R mutant of P450 2B6 exhibits alterations in substrate metabolism and inactivation
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.105.003749
– volume: 280
  start-page: 19569
  year: 2005
  ident: 10.1016/j.bbagen.2006.07.006_bib41
  article-title: Directed evolution of mammalian cytochrome P450 2B1: mutations outside of the active site enhance the metabolism of several substrates, including the anticancer prodrugs cyclophosphamide and ifosfamide
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M500158200
– volume: 338
  start-page: 386
  year: 2005
  ident: 10.1016/j.bbagen.2006.07.006_bib20
  article-title: Roles of the threonine 407, aspartic acid 417, and threonine 419 residues in P450 2B1 in metabolism
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2005.08.192
– volume: 435
  start-page: 157
  year: 2005
  ident: 10.1016/j.bbagen.2006.07.006_bib16
  article-title: Functional role of residues in the helix B′ region of cytochrome P450 2B1
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1016/j.abb.2004.12.014
– volume: 281
  start-page: 8051
  year: 2006
  ident: 10.1016/j.bbagen.2006.07.006_bib14
  article-title: Conformational flexibility of mammalian cytochrome P4502B4 in binding imidazole inhibitors with different ring chemistry and side chains—Solution thermodynamics and molecular modeling
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M509696200
– volume: 279
  start-page: 27294
  year: 2004
  ident: 10.1016/j.bbagen.2006.07.006_bib12
  article-title: Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl)imidazole at 1.9-A resolution: insight into the range of P450 conformations and the coordination of redox partner binding
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M403349200
– volume: 33
  start-page: 910
  year: 2005
  ident: 10.1016/j.bbagen.2006.07.006_bib40
  article-title: Possible pathway(s) of testosterone egress from the active site of cytochrome P450 2B1: a steered molecular dynamics simulation
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.105.004200
– volume: 42
  start-page: 6370
  year: 2003
  ident: 10.1016/j.bbagen.2006.07.006_bib31
  article-title: Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes
  publication-title: Biochemistry
  doi: 10.1021/bi0273922
– volume: 1545
  start-page: 114
  year: 2001
  ident: 10.1016/j.bbagen.2006.07.006_bib53
  article-title: Rational evolution of a medium chain-specific cytochrome P-450 BM-3 variant
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/S0167-4838(00)00268-5
– volume: 42
  start-page: 401
  year: 2006
  ident: 10.1016/j.bbagen.2006.07.006_bib26
  article-title: Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an adult AIDS clinical trials group study
  publication-title: Clin. Infect. Dis.
  doi: 10.1086/499364
– volume: 300
  start-page: 549
  year: 2002
  ident: 10.1016/j.bbagen.2006.07.006_bib45
  article-title: Effect of 17-alpha-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.300.2.549
– volume: 339
  start-page: 371
  issue: Pt. 2
  year: 1999
  ident: 10.1016/j.bbagen.2006.07.006_bib42
  article-title: Roles of key active-site residues in flavocytochrome P450 BM3
  publication-title: Biochem. J.
  doi: 10.1042/0264-6021:3390371
– volume: 100
  start-page: 13196
  year: 2003
  ident: 10.1016/j.bbagen.2006.07.006_bib11
  article-title: An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.2133986100
– volume: 311
  start-page: 855
  year: 2004
  ident: 10.1016/j.bbagen.2006.07.006_bib22
  article-title: The functional role of threonine-205 in the mechanism-based inactivation of P450 2B1 by two ethynyl substrates: the importance of the F helix in catalysis
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.104.071670
– volume: 19
  start-page: 444
  year: 2004
  ident: 10.1016/j.bbagen.2006.07.006_bib30
  article-title: Functional characterization of single nucleotide polymorphisms with amino acid substitution in CYP1A2, CYP2A6, and CYP2B6 found in the Japanese population
  publication-title: Drug Metab. Pharmacokinet.
  doi: 10.2133/dmpk.19.444
– volume: 26
  start-page: 1179
  year: 1998
  ident: 10.1016/j.bbagen.2006.07.006_bib44
  article-title: Molecular basis of P450 inhibition and activation: implications for drug development and drug therapy
  publication-title: Drug Metab. Dispos.
– volume: 30
  start-page: 86
  year: 2002
  ident: 10.1016/j.bbagen.2006.07.006_bib39
  article-title: Combined three-dimensional quantitative structure–activity relationship analysis of cytochrome P450 2B6 substrates and protein homology modeling
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.30.1.86
– volume: 291
  start-page: 176
  year: 1991
  ident: 10.1016/j.bbagen.2006.07.006_bib2
  article-title: Functional expression of mammalian cytochromes P450IIB in the yeast Saccharomyces cerevisiae
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1016/0003-9861(91)90121-X
– volume: 394
  start-page: 21
  year: 2001
  ident: 10.1016/j.bbagen.2006.07.006_bib33
  article-title: The role of cytochrome B1 substrate recognition site residues 115, 294, 297, 298, and 362 in the oxidation of steroids and 7-alkoxycoumarins
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1006/abbi.2001.2504
– volume: 279
  start-page: 35630
  year: 2004
  ident: 10.1016/j.bbagen.2006.07.006_bib35
  article-title: The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M405427200
– volume: 42
  start-page: 408
  year: 2006
  ident: 10.1016/j.bbagen.2006.07.006_bib55
  article-title: Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance
  publication-title: Clin. Infect. Dis.
  doi: 10.1086/499369
– volume: 15
  start-page: 1407
  year: 2002
  ident: 10.1016/j.bbagen.2006.07.006_bib17
  article-title: Substrate routes to the buried active site may vary among cytochromes P450: mutagenesis of the F–G region in P450 2B1
  publication-title: Chem. Res. Toxicol.
  doi: 10.1021/tx020057u
– volume: 266
  start-page: 22515
  year: 1991
  ident: 10.1016/j.bbagen.2006.07.006_bib4
  article-title: Molecular basis for a functionally unique cytochrome P450IIB1 variant
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)54602-0
– volume: 260
  start-page: 16122
  year: 1985
  ident: 10.1016/j.bbagen.2006.07.006_bib8
  article-title: The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(17)36209-9
– volume: 59
  start-page: 475
  year: 2001
  ident: 10.1016/j.bbagen.2006.07.006_bib38
  article-title: Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles
  publication-title: Mol. Pharmacol.
  doi: 10.1124/mol.59.3.475
– volume: 21
  start-page: 474
  year: 2003
  ident: 10.1016/j.bbagen.2006.07.006_bib54
  article-title: Directed evolution of enzymes for applied biocatalysis
  publication-title: Trends Biotechnol.
  doi: 10.1016/j.tibtech.2003.09.001
– volume: 4
  start-page: 515
  year: 2003
  ident: 10.1016/j.bbagen.2006.07.006_bib1
  article-title: Transcriptional regulation of cytochrome P4502B genes by nuclear receptors
  publication-title: Curr. Drug Metab.
  doi: 10.2174/1389200033489262
– volume: 16
  start-page: 1
  year: 2005
  ident: 10.1016/j.bbagen.2006.07.006_bib36
  article-title: In silico modelling of ADMET—a minireview of work from 2000 to 2004
  publication-title: SAR QSAR Environ. Res.
  doi: 10.1080/10629360412331319835
SSID ssj0000595
ssj0025309
Score 2.1176808
SecondaryResourceType review_article
Snippet In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure–function through determination of one ligand-free and two...
In the last 4 years, breakthroughs were made in the field of P450 2B (CYP2B) structure-function through determination of one ligand-free and two...
SourceID osti
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 402
SubjectTerms Animals
Aryl Hydrocarbon Hydroxylases - chemistry
Aryl Hydrocarbon Hydroxylases - genetics
BASIC BIOLOGICAL SCIENCES
Binding Sites
BIOCHEMISTRY
BIOPHYSICS
Conformation
CYP2B
Cytochrome P-450 CYP2B6
Cytochrome P-450 Enzyme System - chemistry
Cytochrome P-450 Enzyme System - genetics
Cytochrome P450
Cytochrome P450 Family 2
CYTOCHROMES
Function
Humans
Models, Molecular
Mutagenesis, Site-Directed
Mutation
Other,OTHER
Oxidoreductases, N-Demethylating - chemistry
Oxidoreductases, N-Demethylating - genetics
Polymorphism, Genetic
Structure
Structure-Activity Relationship
Substrate specificity
Thermodynamics
Title Structure–function analysis of cytochromes P450 2B
URI https://dx.doi.org/10.1016/j.bbagen.2006.07.006
https://www.ncbi.nlm.nih.gov/pubmed/16935426
https://www.proquest.com/docview/68948750
https://www.osti.gov/biblio/910100
Volume 1770
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB7WFdGL-HZ99uC1brtN0ua4LsrqoogP9FbSNEFFWtH14EX8D_5Df4kzbap4EMFToWQgzCQz33Sm3wDsWEQNxoaJr-NM-ixKMrxzXPhCCpNn0jJRjek8PhHDS3Z0za9bMGj-haG2Suf7a59eeWv3puu02X24ve2eU1EP4QQx5FE5DfP2yV4kBR7tyf7haHjy7ZB5NXyF1vsk0PxBV7V5ZRne28JVJYjOUPwWodolXrrfgWgVkA7mYNYhSa9fb3YeWqZYgKl6tuTLAkwPmlFui8DOK5bY50fz8fZOkYys4SnHR-KV1tMv41LfEHXBk3fKeOD19pbg8mD_YjD03bgEX0ciHvvMyhxTzjgPVWI0hnqlGcKhxMjc8jjPE2aETnpSiQxzFmEk2kTGFvGMFjbhQbQM7aIszCp4NoulzDE74SZm2jAVaqMiLbXiVmFY7UDUqCjVjkucRlrcp03T2F1aK5bGXIo0oCK36ID_JfVQc2n8sT5utJ_-OBMpuvs_JNfIWCRFVLiaeoZQDKFRGAQd2G5MmKIdqECiClM-P6UikZS_4YqV2rLf2xQy4ghm1v69pXWYqT8LU_vaBrTR7mYT8cw424KJ3ddwy51aeo7Orkaf4d_0Nw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB5kRfQivl2fPXit29okbY66KOtrEVTwFtI0wRVpF10PXsT_4D_0lzjTh4uHZcFrSSDMZGa-6Uy-AThwiBqsCxPfxKn0WZSkaHNc-EIKm6XSMVGO6bzui949u3jgDzPQbd7CUFtl7fsrn1566_pLp5ZmZzgYdG6pqIdwghjyqJyGefssQ_Ml6zz8GPd5IH7gVSmB-bS8eT9XNnmlKVptXtckiMxQTIpPrQJNbjIMLcPR2RIs1jjSO66OugwzNl-BuWqy5PsKzHebQW6rwG5Ljti3F_v9-UVxjHTh6ZqNxCucZ95HhXkk4oJX74bxwDs6WYP7s9O7bs-vhyX4JhLxyGdOZphwxlmoE2sw0GvDEAwlVmaOx1mWMCtMciS1SDFjEVaiRmTsEM0Y4RIeROvQyovcboLn0ljKDHMTbmNmLNOhsToy0mjuNAbVNkSNiJSpmcRpoMWzalrGnlQlWBpyKVRAJW7RBv9317Bi0piyPm6kr_7cCIXOfsrOLVIW7SIiXEMdQ7gNgVEYBG3Yb1SoUA9UHtG5Ld5elUgkZW-4YqPS7PiYQkYcoczWv4-0D_O9u-srdXXev9yGheoHMTWy7UAL74DdRWQzSvfKm_sDPlfzWA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structure-Function+Analysis+of+Cytochromes+P450+2b&rft.jtitle=Biochimica+et+biophysica+acta&rft.au=Zhao%2C+Y.&rft.au=Halpert%2C+J.R.&rft.date=2007-03-01&rft.issn=0006-3002&rft.eissn=1878-2434&rft.volume=1770&rft_id=info:doi/10.1016%2Fj.bbagen.2006.07.006&rft.externalDocID=910100
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon